Zomedica Corp. financial data

Symbol
ZOM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Phoenix Drive, Suite 125, Ann Arbor, MI
State of incorporation
Alberta, Canada
Fiscal year end
December 31
Former names
Zomedica Pharmaceuticals Corp. (to 9/28/2020)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.12K % -33.2%
Quick Ratio 64.1 % +51.4%
Debt-to-equity 5.37 % -3.07%
Return On Equity -15.4 % -171%
Return On Assets -14.6 % -172%
Operating Margin -430 % -307%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 980M shares 0%
Common Stock, Shares, Outstanding 980M shares 0%
Entity Public Float 193M USD -9.27%
Common Stock, Value, Issued 381M USD 0%
Weighted Average Number of Shares Outstanding, Basic 980M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 980M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.02M USD -70.7%
Cost of Revenue 1.89M USD -74.9%
Research and Development Expense 3.4M USD +1.77%
Selling and Marketing Expense 3.89M USD +16.9%
General and Administrative Expense 6.77M USD +10.6%
Operating Income (Loss) -30.2M USD -19.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -32.4M USD -82.2%
Income Tax Expense (Benefit) 1.66M USD +98.6%
Net Income (Loss) Attributable to Parent -34M USD -128%
Earnings Per Share, Basic -0.03 USD/shares -200%
Earnings Per Share, Diluted -0.06 USD/shares -500%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.75M USD -55.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.76M USD +30.5%
Inventory, Net 5.43M USD +45.3%
Assets, Current 87.3M USD -24.4%
Property, Plant and Equipment, Net 25.5M USD +209%
Operating Lease, Right-of-Use Asset 1.83M USD +8.75%
Intangible Assets, Net (Excluding Goodwill) 51.6M USD -9.33%
Goodwill 45.6M USD -38.2%
Other Assets, Noncurrent 1.14M USD +34.2%
Assets 214M USD -22.2%
Accounts Payable, Current 2.38M USD
Employee-related Liabilities, Current 2.83M USD
Accrued Liabilities, Current 4.67M USD
Contract with Customer, Liability, Current 293K USD +14%
Liabilities, Current 8.06M USD +19.6%
Contract with Customer, Liability, Noncurrent 260K USD -3.7%
Deferred Income Tax Liabilities, Net 694K USD -30.5%
Operating Lease, Liability, Noncurrent 1.45M USD +34.7%
Other Liabilities, Noncurrent 808K USD -43.6%
Liabilities 11.3M USD -20.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 300K USD
Retained Earnings (Accumulated Deficit) -211M USD -41.9%
Stockholders' Equity Attributable to Parent 203M USD -22.2%
Liabilities and Equity 214M USD -22.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.59M USD -78.3%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 5.63M USD
Common Stock, Shares, Issued 980M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.68M USD -101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.75M USD -55.3%
Deferred Tax Assets, Valuation Allowance 23.4M USD +23.4%
Deferred Tax Assets, Gross 30.4M USD +23.8%
Operating Lease, Liability 2.73M USD +57.1%
Depreciation 1.39M USD +128%
Payments to Acquire Property, Plant, and Equipment 2.34M USD +141%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -34M USD -134%
Lessee, Operating Lease, Liability, to be Paid 3.11M USD +66.8%
Property, Plant and Equipment, Gross 28.5M USD +183%
Operating Lease, Liability, Current 632K USD -6.92%
Lessee, Operating Lease, Liability, to be Paid, Year Two 632K USD -6.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.07M USD +51.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +44.4%
Deferred Income Tax Expense (Benefit) -184K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 377K USD +202%
Lessee, Operating Lease, Liability, to be Paid, Year Three 603K USD +154%
Unrecognized Tax Benefits 265K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 569K USD +189%
Operating Lease, Payments 1.07M USD +152%
Amortization of Intangible Assets 6.41M USD +29.1%
Share-based Payment Arrangement, Expense 3.54M USD -46.4%
Interest Expense 50K USD